Understand menopause-related dryness, painful sex and urinary changes, with context on lubricants, moisturizers and clinician-guided care.
Menopause is not a reason to endure painful sex.
Vaginal dryness and urinary changes are recognized menopause-associated concerns, not personal failures or proof that intimacy must become uncomfortable.
The useful question is which symptom needs attention and what kind of support fits it.
Menopause is a life stage, not a diagnosis of sexual dysfunction. A change in comfort deserves its own description rather than a broad assumption that sexual wellbeing is declining. Our broader introduction to menopause and intimacy places these concerns within the wider transition.
The term genitourinary syndrome of menopause, or GSM, describes genital and urinary symptoms associated with lower estrogen. It includes vaginal dryness and irritation, pain with sex and urinary complaints. The term names a group of symptoms, not an experience everyone will have.
These changes are more specific than a general sense that sex feels different. Describing the type of discomfort gives a conversation a clearer starting point:
The Menopause Society describes GSM as affecting physical comfort, sexual health and urinary function. That broader picture matters because a question about vaginal dryness may not capture everything a person is experiencing.
The emotional context also deserves attention. In its 2026 menopause report, East and North Hertfordshire Teaching NHS Trust says embarrassment and concern about not being taken seriously can keep people from mentioning dryness or painful sex. It includes bladder problems among these under-discussed concerns.
Daily circumstances are worth describing as well. Have routines changed? Are stress or relationship expectations part of the concern? These are useful questions to bring alongside physical symptoms, not reasons to assume the symptoms are psychological.
Physical comfort and sexual desire are different questions. A person may want closeness while wanting to avoid an uncomfortable activity. Another may be concerned about everyday irritation without wanting to discuss sexual activity at all.
There is no single priority that everyone should adopt. One person may want relief from dryness between sexual experiences. Someone else may be most concerned about urinary symptoms or about pain interrupting an otherwise satisfying relationship.
Symptoms also do not define sexual identity or relationship priorities. Being partnered does not create an obligation to pursue a particular activity. Being single does not make ongoing discomfort less worthy of care.
This is why an individual conversation is more useful than an age-based prediction. Asking what has changed and what matters to the person leaves room for different needs. It also avoids treating a symptom label as a complete description of someone's sexual life.
Our discussion of sexual function beyond age-based assumptions offers a wider perspective on that distinction.
The practical comparison starts with purpose. A lubricant intended for sexual activity is not the same as a moisturizer intended for ongoing comfort. Clinician-guided local treatment addresses another set of questions about symptoms and suitability.
UCLA Health describes lubricants as products designed for use before intercourse. Their role is to reduce friction during sexual activity.
That makes lubrication relevant when friction is part of the discomfort being described. It does not make a lubricant a complete answer to every genital or urinary symptom. The useful distinction is between helping an activity feel more comfortable and assessing why symptoms are occurring.
UCLA Health distinguishes moisturizers as regular-use products intended for ongoing vaginal comfort. They serve a different purpose from a product used immediately before sexual activity.
This difference is practical rather than merely a matter of product names. A person seeking help for dryness outside sexual activity is describing a different need from someone asking about friction during intercourse. Nonhormonal products can be used alone for limited symptoms or alongside other care, according to UCLA Health.
When symptoms persist or become more bothersome, local vaginal estrogen is among the options a clinician can discuss. UCLA Health describes forms including creams, suppositories or vaginal rings as potentially relieving dryness and painful sex when these are the main symptoms.
This is a specific treatment discussion rather than a recommendation to use hormones for every midlife change. The symptom being addressed matters. So do the person's medical history and preferences.
The report on unreported genitourinary symptoms supports individualized evaluation rather than automatically attributing ongoing or painful symptoms to menopause. Questions about treatment suitability belong in that clinical discussion.
Urinary concerns should not be folded into a product choice for vaginal dryness. The Menopause Society describes urgency and frequency, burning and recurrent urinary tract infections within the broader symptom context.
It also describes vaginal estrogen as an effective option for preventing recurrent UTIs in postmenopausal and perimenopausal women. That is a reason to discuss repeated infections with a clinician, not to assume a lubricant addresses their cause.
The questions are different: What is causing the current urinary complaint? Is prevention of recurrent infections relevant? A general article cannot settle those individual decisions.
The available evidence does not establish one product or estrogen formulation as best for everyone. Adjustments to sexual activity are comfort options, not a tested step-by-step treatment protocol. These distinctions help keep practical choices separate from claims of proven clinical benefit.
In an October 2026 report, The Menopause Society described a small pilot of microablative fractional radiofrequency. It explicitly cautioned that the study was not designed to demonstrate clinical effectiveness. That report does not establish an energy-based procedure as an effective treatment for GSM.
Penetration is not an obligation when it is uncomfortable. Pausing or changing an activity can be discussed as a choice about comfort. Lubrication is another option when friction is relevant.
A conversation can separate several questions that might otherwise become tangled together: whether closeness is wanted, whether a particular activity feels comfortable and whether a symptom needs medical attention. These questions do not have to share the same answer.
Mismatched desire can be discussed without treating discomfort as rejection or assuming that more sexual activity is the required goal. The starting point can be what each person wants and what feels acceptable now.
Routines and practical demands can be part of that conversation too. When stress or caregiving is relevant, it can be named without being used to explain away a physical symptom. Adjusting intimacy and seeking assessment are compatible choices, not competing approaches.
A useful next step is to describe the concern before deciding what it means. That can keep a discussion focused on the symptom rather than on a broad fear about aging or sexual function.
Questions worth considering include:
For someone preparing to describe a change, our guide to noticing and recording sexual-function concerns provides a related starting point. There is no need to arrive with a diagnosis already chosen.
Persistent pain and urinary concerns warrant a conversation with a qualified health professional. That discussion can distinguish symptom relief from questions that need assessment. Our overview of preparing for a sexual-health appointment offers further context.
The aim is not to turn every variation into a medical problem. It is to avoid making endurance the default when a symptom is bothersome and options are available.
Comfort belongs in the story of midlife, not at its margins.
Menopause-associated discomfort should not be reduced to a product choice, and Sexential explains sexual function through both biology and daily life. Its educational coverage helps adults aged 35 to 65 understand possible influences on changing sexual experiences without selecting treatments or providing personalised medical advice.
Follow Sexential for thoughtful guidance on desire, sexual function, hormones, confidence, relationships and intimacy. Explore new articles and evidence-aware resources for sexual wellbeing across adulthood.
A report on a student survey links attention with men’s sexual satisfaction. Here’s the evidence, its limits and the practical context for midlife.
A new report puts men’s midlife testosterone changes in context, with guidance on assessment, partner conversations and fertility considerations.
The Menopause Society’s 2026 program places lifestyle, sleep and sexual health together. Here is what the agenda and partner research actually report.
Explore practical resources on desire, function, hormones, confidence, intimacy and sexual wellbeing.
Read the Blog
